Search research articles
Contact Us
Filters
Showing results (21-30 of 124) with videos related to
Page
of 13
Sort By:
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
|
July 8, 2011
Changing incidence and subtypes of ALS in Modena, Italy: A 10-years prospective study
Eleni Georgoulopoulou, Marco Vinceti, Francesca Bonvicini, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
January 3, 2026
Atypical clinical and MRI features in Leber hereditary optic neuropathy: a case series of four patients
Giulia De Napoli, Diana Ferraro, Alessia Fiore, et al.
The Neurologist
|
June 16, 2015
Methylprednisolone-induced Toxic Hepatitis After Intravenous Pulsed Therapy for Multiple Sclerosis Relapses
Diana Ferraro, Vincenzo G Mirante, Luisa Losi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 17, 2010
Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM
Patrizia Sola, Jessica Mandrioli, Anna M Simone, et al.
Acta Neurologica Scandinavica
|
July 28, 2019
Plasma neurofilaments correlate with disability in progressive multiple sclerosis patients
Diana Ferraro, Claudio Guicciardi, Sara De Biasi, et al.
Clinical Chemistry and Laboratory Medicine
|
December 27, 2025
Kappa Index predicts disease activity and transition to high-efficacy therapies in multiple sclerosis
Simone Marcheselli, Federica Galota, Patrizia Natali, et al.
Journal of Neuroimmunology
|
February 26, 2013
Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome
Diana Ferraro, Anna Maria Simone, Roberta Bedin, et al.
Current Neuropharmacology
|
October 25, 2023
Ocrelizumab Extended Interval Dosing in Primary Progressive Multiple Sclerosis: An Italian Experience
Aurora Zanghì, Diana Ferraro, Graziella Callari, et al.
Cells
|
April 25, 2025
Impact of High-Efficacy Therapies for Multiple Sclerosis on B Cells
Federica Galota, Simone Marcheselli, Sara De Biasi, et al.
Cells
|
December 24, 2021
Modulation of Tregs and iNKT by Fingolimod in Multiple Sclerosis Patients
Diana Ferraro, Sara De Biasi, Anna Maria Simone, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 124) with videos related to
Sort By:
Page
of 13
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
|
July 8, 2011
Changing incidence and subtypes of ALS in Modena, Italy: A 10-years prospective study
Eleni Georgoulopoulou, Marco Vinceti, Francesca Bonvicini, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
January 3, 2026
Atypical clinical and MRI features in Leber hereditary optic neuropathy: a case series of four patients
Giulia De Napoli, Diana Ferraro, Alessia Fiore, et al.
The Neurologist
|
June 16, 2015
Methylprednisolone-induced Toxic Hepatitis After Intravenous Pulsed Therapy for Multiple Sclerosis Relapses
Diana Ferraro, Vincenzo G Mirante, Luisa Losi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 17, 2010
Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM
Patrizia Sola, Jessica Mandrioli, Anna M Simone, et al.
Acta Neurologica Scandinavica
|
July 28, 2019
Plasma neurofilaments correlate with disability in progressive multiple sclerosis patients
Diana Ferraro, Claudio Guicciardi, Sara De Biasi, et al.
Clinical Chemistry and Laboratory Medicine
|
December 27, 2025
Kappa Index predicts disease activity and transition to high-efficacy therapies in multiple sclerosis
Simone Marcheselli, Federica Galota, Patrizia Natali, et al.
Journal of Neuroimmunology
|
February 26, 2013
Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome
Diana Ferraro, Anna Maria Simone, Roberta Bedin, et al.
Current Neuropharmacology
|
October 25, 2023
Ocrelizumab Extended Interval Dosing in Primary Progressive Multiple Sclerosis: An Italian Experience
Aurora Zanghì, Diana Ferraro, Graziella Callari, et al.
Cells
|
April 25, 2025
Impact of High-Efficacy Therapies for Multiple Sclerosis on B Cells
Federica Galota, Simone Marcheselli, Sara De Biasi, et al.
Cells
|
December 24, 2021
Modulation of Tregs and iNKT by Fingolimod in Multiple Sclerosis Patients
Diana Ferraro, Sara De Biasi, Anna Maria Simone, et al.
Page
of 13